Crescent Biopharma (CBIO) Current Leases (2019 - 2026)
Crescent Biopharma (CBIO) reported Current Leases of $453000.0 for Q1 2026, up 4.14% quarter-over-quarter from $435000.0 in Q4 2025.
Crescent Biopharma (CBIO) Current Leases (2019 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has 8 years of Current Leases data on file, last reported at $453000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $453000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $453000.0 (changed N/A YoY), and the FY2025 annual result was $435000.0, changed N/A from the prior year.
- Current Leases advanced to $453000.0 in Q1 2026 per CBIO's latest filing, from $435000.0 in the prior quarter.
- Over five years, Current Leases peaked at $1.1 million in Q3 2022 and troughed at $200000.0 in Q2 2025.
- A 5-year average of $659842.9 and a median of $651734.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases plunged 65.03% in 2024, then surged 59.08% in 2025.
- A 5-year view of Current Leases shows it stood at $918555.0 in 2022, then fell by 19.27% to $741558.0 in 2023, then sank by 64.65% to $262133.0 in 2024, then soared by 65.95% to $435000.0 in 2025, then grew by 4.14% to $453000.0 in 2026.
- Business Quant data shows CBIO's Current Leases at $453000.0 in Q1 2026, $435000.0 in Q4 2025, and $417000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - | 453,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 453,000.00 |
| Dec 31, 2025 | 435,000.00 |
| Sep 30, 2025 | 417,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Sep 30, 2024 | 262,133.00 |
| Jun 30, 2024 | 448,775.00 |
| Mar 31, 2024 | 630,827.00 |
| Dec 31, 2023 | 741,558.00 |
| Sep 30, 2023 | 749,618.00 |
| Jun 30, 2023 | 820,243.00 |
| Mar 31, 2023 | 651,734.00 |
| Dec 31, 2022 | 918,555.00 |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 974,816.00 |
| Jun 30, 2021 | 948,787.00 |
| Mar 31, 2021 | 923,433.00 |
| Dec 31, 2020 | 898,549.00 |